| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 468 | 2020 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 418 | 2022 |
| Differential expression of microRNAs in hematopoietic cell lineages M Merkerova, M Belickova, H Bruchova European journal of haematology 81 (4), 304-310, 2008 | 304 | 2008 |
| Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome M Dostalova Merkerova, Z Krejcik, H Votavova, M Belickova, A Vasikova, ... European journal of human genetics 19 (3), 313-319, 2011 | 108 | 2011 |
| MicroRNA expression profiles in umbilical cord blood cell lineages M Merkerova, A Vasikova, M Belickova, H Bruchova Stem cells and development 19 (1), 17-26, 2010 | 105 | 2010 |
| Clonality in juvenile chronic myelogenous leukemia L Busque, DG Gilliland, JT Prchal, CA Sieff, HJ Weinstein, JM Sokol, ... | 93 | 1995 |
| Differential expression of microRNAs in CD34+ cells of 5q-syndrome H Votavova, M Grmanova, M Dostalova Merkerova, M Belickova, ... Journal of hematology & oncology 4, 1-6, 2011 | 81 | 2011 |
| Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism. JT Prchal, JF Prchal, M Belickova, S Chen, Y Guan, GL Gartland, ... The Journal of experimental medicine 183 (2), 561-567, 1996 | 67 | 1996 |
| TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes M Belickova, J Vesela, A Jonasova, B Pejsova, H Votavova, ... Oncotarget 7 (24), 36266, 2016 | 59 | 2016 |
| 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU. 1 gene and cell differentiation capacity N Curik, P Burda, K Vargova, V Pospisil, M Belickova, P Vlckova, ... Leukemia 26 (8), 1804-1811, 2012 | 59 | 2012 |
| A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome A Vasikova, M Belickova, E Budinska, J Cermak Leukemia Research 34 (12), 1566-1572, 2010 | 53 | 2010 |
| Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia. H Cechova, P Lassuthova, L Novakova, M Belickova, R Stemberkova, ... Neoplasma 59 (2), 168-174, 2012 | 38 | 2012 |
| Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with … K Svobodova, Z Zemanova, H Lhotska, M Novakova, L Podskalska, ... Leukemia research 42, 7-12, 2016 | 36 | 2016 |
| Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome A Hrustincova, Z Krejcik, D Kundrat, K Szikszai, M Belickova, ... Cells 9 (4), 794, 2020 | 32 | 2020 |
| A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55. M Luhovy, Y Liu, M Belickova, JF Prchal, JT Prchal Biology of Blood and Marrow Transplantation: Journal of the American Society …, 1995 | 27 | 1995 |
| Genome‐wide mi RNA profiling in myelodysplastic syndrome with del (5q) treated with lenalidomide MD Merkerova, Z Krejcik, M Belickova, A Hrustincova, J Klema, E Stara, ... European Journal of Haematology 95 (1), 35-43, 2015 | 25 | 2015 |
| TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, T Yoshizato, RP Hasserjian, R Saiki, Y Shiozawa, ... Blood 134, 675, 2019 | 23 | 2019 |
| MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia Z Krejcik, M Belickova, A Hrustincova, H Votavova, A Jonasova, J Cermak, ... Cancer Biomarkers 22 (1), 101-110, 2018 | 23 | 2018 |
| DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population M Belickova, MD Merkerova, E Stara, J Vesela, D Sponerova, ... Journal of Hematology & Oncology 6, 1-6, 2013 | 22 | 2013 |
| Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q-syndrome and in Diamond–Blackfan anemia R Neuwirtova, O Fuchs, M Holicka, M Vostry, A Kostecka, H Hajkova, ... Annals of hematology 92, 11-18, 2013 | 22 | 2013 |
